Cost-effectiveness calculations from trials

Journal of Hypertension, Supplement

Volumn 14, Issue 2, 1996, Pages

  Ambrosioni, Ettore ^a   Costa, Francesco Vittorio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antihypertensive treatment; Cardiovascular risk; Cost effectiveness; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

EID: 0029853887     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199609002-00011     Document Type: Conference Paper

References (5)

1. Moser M: Current hypertension management: separating fact from fiction. Cleveland Clin J Med 1993, 60:27-37.
2. Pauly MV, Stason WB: Contemporary considerations In the treatment of hypertension: cost, efficacy, preference. Am J Med 1986, 81:1 -2.
3. Menard J, Cornu P, Day M: Cost of hypertension treatment and the price of health. J Hum Hypertens 1994, 6:447-458.
4. Anonymous: Arterial hypertension and therapeutic compliance [in Italian]. IMS 1995,55:12-25.
5. Siegler M: Falling off the pedestal: what Is happening to the traditional doctor-patient relationship? Mayo Clin Pioc 1993, 68:461-467.